A Prospective Phase I/II Trial of Bortezomib-Based Graft-Versus-Host-Disease Prophylaxis in HLA-Mismatched Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation: Encouraging Safety, Efficacy, and Survival
Saved in:
Published in | Biology of blood and marrow transplantation Vol. 17; no. 2; pp. S165 - S166 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
ISSN: | 1083-8791 1523-6536 |
---|---|
DOI: | 10.1016/j.bbmt.2010.12.044 |